Seminars in Hematology
Volume 44, Issue 4 , Pages 220-226 , October 2007

Activity Survey and Historical Perspective of Autologous Stem Cell Transplantation in Europe

  • Alois Gratwohl

      Affiliations

    • Corresponding Author InformationAddress correspondence to Alois Gratwohl, MD, Hematology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland.

References 

  1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. 2006;354:1813–1826
  2. Thomas ED. The Nobel Lectures in Immunology (The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation—Past, present and future). Scand J Immunol. 1994;39:339–345
  3. Thomas ED, Storb R, Clift RA, Fefer A, Johnson L, Neiman PE, et al. Bone-marrow transplantation (second of two parts). N Engl J Med. 1975;292:895–902
  4. Mathe G. Hematopoietic cell grafts and their applications. Presse Med. 1964;72:2391–2394
  5. Lorenz E, Uphoff D, Reid TR, Shelton E. Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst. 1951;12:197–201
  6. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366–1369
  7. Bach FH, Albertini RJ, Joo P, Anderson JL, Bortin MM. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364–1366
  8. Gratwohl A, Hermans J. Indications and donor source of hematopoietic stem cell transplants in Europe 1993: report from the European Group for Blood and Marrow Transplantation (EBMT). Clin Transplant. 1995;9:355–363
  9. Gorin NC, Herzig G, Bull MI, Graw RG. Related Articles, Long-term preservation of bone marrow and stem cell pool in dogs. Blood. 1978;51:257–265
  10. Bowles CA, Bull M, McCormick K, Kadin M, Lucas D. Autologous bone marrow transplantation following chemotherapy and irradiation in dogs with spontaneous lymphomas. J Natl Cancer Inst. 1980;65:615–620
  11. Appelbaum FR, Buckner CD. Overview of the clinical relevance of autologous bone marrow transplantation. Clin Haematol. 1986;15:1–18
  12. Gorin NC. Autologous bone marrow transplantation in hematological malignancies. Eur J Cancer Clin Oncol. 1984;20:1–9
  13. Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R, Thomas ED. Treatment of blastic transformation of chronic granulocytic leukemia by high dose cyclophosphamide, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol. 1974;2:138–146
  14. Goldman JM, Deisseroth AB. Use of autotransplants in chronic myeloid leukaemia. Bone Marrow Transplant. 1992;10(suppl 1):74–76
  15. Reiffers J, Trouette R, Marit G, Montastruc M, Faberes C, Cony-Makhoul P, et al. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: A report of 47 cases. Br J Haematol. 1991;77:339–345
  16. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma. N Engl J Med. 1987;316:1493–1498
  17. Lippman ME. High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. N Engl J Med. 2000;342:1119–1120
  18. McCarthy M. Unproven breast-cancer therapy widely used in USA. Lancet. 1996;347:1617
  19. Farquhar C, Basser R, Marjoribanks J, Lethaby A: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer. Cochrane Database Syst Rev (1):CD003139, 2003. Update in Cochrane Database Syst Rev (3):CD003139, 2005
  20. Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med. 2003;349:2495–2502
  21. Harousseau JL, Attal M, Divine M, Marit G, Leblond V, Stoppa AM, et al. Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the French Registry on Autologous Transplantation in Multiple Myeloma. Blood. 1995;85:3077–3085
  22. Milpied N, Deconinck E, Gaillard F, Delwail V, Foussard C, Berthou C, et al. Groupe Ouest-Est des Leucemies et des Autres Maladies du Sang (Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support). N Engl J Med. 2004;350:1287–1295
  23. Vignot S, Mounier N, Larghero J, Brice P, Quero L, de Bazelaire C, et al. High-dose therapy and autologous stem-cell transplantation can improve event-free survival for indolent lymphoma: A study using patients as their own controls. Cancer. 2007;109:60–67
  24. Philip T, Biron P. High-dose chemotherapy and autologous bone marrow transplantation in diffuse intermediate- and high-grade non-Hodgkin lymphoma. Crit Rev Oncol Hematol. 2002;41:213–223
  25. Thomas X, Suciu S, Rio B, Leone G, Broccia G, Fillet G, et al. Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: Results of the prospective EORTC-GIMEMA AML-13 study. Haematologica. 2007;92:389–396
  26. de Witte T, Brand R, van Biezen A, Delforge M, Biersack H, Or R, et al. MDS subcommittee of the EBMT Chronic Leukemia Working Party The role of stem cell source in autologous hematopoietic stem cell transplantation for patients with myelodysplastic syndromes. Haematologica. 2006;91:750–756
  27. Breems DA, Boogaerts MA, Dekker AW, Van Putten WL, Sonneveld P, Huijgens PC, et al. Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: A prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial. Br J Haematol. 2006;128:59–65
  28. Gratwohl A. Bone marrow transplantation activity in Europe 1990 (European Group for Bone Marrow Transplantation (EBMT)). Bone Marrow Transplant. 1991;8:197–201
  29. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D Joint Accreditation Committee of the International Society for Cellular Therapy ISCT European Group for Blood and Marrow Transplantation EBMT. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: Focus on increasing use of unrelated donors. Bone Marrow Transplant. 2007;39:71–87
  30. Dazzi F, van Laar JM, Cope A, Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther. 2007;9:206
  31. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, et al. Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005;35:869–879
  32. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: A report of the EBMT activity survey 2003. Bone Marrow Transplant. 2005;36:575–590
  33. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in hematopoietic stem cell transplantation in Europe. Blood. 2002;100:2374–2386
  34. Gratwohl A, Baldomero H, Demirer T, Rosti G, Dini G, Ladenstein R, et al. Accreditation Committee, European Group for Blood and Marrow Transplantation Working Party on Pediatric Diseases Working Party on Solid Tumors Hematopoetic stem cell transplantation for solid tumors in Europe. Ann Oncol. 2004;15:653–660
  35. Gratwohl A, Baldomero H, Passweg J, Frassoni F, Niederwieser D, Schmitz N, et al. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) Working Parties Acute (ALWP) Chronic Leukemias (CLWP) Lymphoma Working Party Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia. 2003;17:941–959
  36. Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of haematopoietic stem cell transplants in Europe. Br J Haematol. 2002;117:451–468
  37. Gratwohl A, Baldomero H, Schwendener A, Gratwohl M, Urbano-Ispizua A, Frauendorfer K. Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe—Impact of cost considerations. Leukemia. 2007;21:383–386
  38. Gajewski JL, Robinson P. Do affluent societies have the only options for the best therapy?. Leukemia. 2007;21:387–388

 Supported in part by the European Leukemia Net LSH-2002-2.2.0-3 and the Swiss National Research Foundation 3200 BO-106 105/1 and by Oncosuisse. See Acknowledgment for complete list of funding.

PII: S0037-1963(07)00127-8

doi: 10.1053/j.seminhematol.2007.09.001

Seminars in Hematology
Volume 44, Issue 4 , Pages 220-226 , October 2007

Article Tools

* Image Usage & Resolution